little gem

just came across this stock today. It seems to be a well managed company with relatively low cash burn (1.2M per annum) with a cancer test that can be used to determine early stage ovarian cancer that will be marketed in second quarter 08
I would think there will be strong market demand for the test as it is more accurate than present CA125 test in detecting cancer in early stage.
In the kitty around 1.6M with some revenue being generated around 150K a quarter
They have an even more accurate ovarian test in earlier stage of development.